![Frontiers | The pharmacokinetics of continuous subcutaneous levodopa/carbidopa infusion: Findings from the ND0612 clinical development program Frontiers | The pharmacokinetics of continuous subcutaneous levodopa/carbidopa infusion: Findings from the ND0612 clinical development program](https://www.frontiersin.org/files/Articles/1036068/fneur-13-1036068-HTML/image_m/fneur-13-1036068-g001.jpg)
Frontiers | The pharmacokinetics of continuous subcutaneous levodopa/carbidopa infusion: Findings from the ND0612 clinical development program
![Efficacy and safety of entacapone in levodopa/carbidopa versus levodopa/ benserazide treated Parkinson's disease patients with wearing-off | SpringerLink Efficacy and safety of entacapone in levodopa/carbidopa versus levodopa/ benserazide treated Parkinson's disease patients with wearing-off | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00702-015-1449-6/MediaObjects/702_2015_1449_Fig2_HTML.gif)
Efficacy and safety of entacapone in levodopa/carbidopa versus levodopa/ benserazide treated Parkinson's disease patients with wearing-off | SpringerLink
![Brain Sciences | Free Full-Text | Advanced Parkinson’s Disease Treatment Simplification and Long-Term Outcomes with Levodopa Carbidopa Intestinal Gel: COSMOS Romanian Subanalysis Brain Sciences | Free Full-Text | Advanced Parkinson’s Disease Treatment Simplification and Long-Term Outcomes with Levodopa Carbidopa Intestinal Gel: COSMOS Romanian Subanalysis](https://www.mdpi.com/brainsci/brainsci-11-01566/article_deploy/html/images/brainsci-11-01566-g001.png)
Brain Sciences | Free Full-Text | Advanced Parkinson’s Disease Treatment Simplification and Long-Term Outcomes with Levodopa Carbidopa Intestinal Gel: COSMOS Romanian Subanalysis
![Efficacy and safety of entacapone in levodopa/carbidopa versus levodopa/ benserazide treated Parkinson's disease patients with wearing-off – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on Efficacy and safety of entacapone in levodopa/carbidopa versus levodopa/ benserazide treated Parkinson's disease patients with wearing-off – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on](https://cyberleninka.org/viewer_images/270172/f/1.png)
Efficacy and safety of entacapone in levodopa/carbidopa versus levodopa/ benserazide treated Parkinson's disease patients with wearing-off – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on
![PDF) L-Dopa Pharmacokinetic Profile with Effervescent Melevodopa/Carbidopa versus Standard-Release Levodopa/Carbidopa Tablets in Parkinson's Disease: A Randomised Study PDF) L-Dopa Pharmacokinetic Profile with Effervescent Melevodopa/Carbidopa versus Standard-Release Levodopa/Carbidopa Tablets in Parkinson's Disease: A Randomised Study](https://i1.rgstatic.net/publication/279232240_L-Dopa_Pharmacokinetic_Profile_with_Effervescent_MelevodopaCarbidopa_versus_Standard-Release_LevodopaCarbidopa_Tablets_in_Parkinson's_Disease_A_Randomised_Study/links/564b21a408ae44e7a28f16dc/largepreview.png)
PDF) L-Dopa Pharmacokinetic Profile with Effervescent Melevodopa/Carbidopa versus Standard-Release Levodopa/Carbidopa Tablets in Parkinson's Disease: A Randomised Study
![PDF) Melevodopa/carbidopa effervescent formulation in the treatment of motor fluctuations in advanced Parkinson's disease | Juan Burguera and Juan Gómez-esteban - Academia.edu PDF) Melevodopa/carbidopa effervescent formulation in the treatment of motor fluctuations in advanced Parkinson's disease | Juan Burguera and Juan Gómez-esteban - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/42029925/mini_magick20190218-15098-1qujxso.png?1550499289)
PDF) Melevodopa/carbidopa effervescent formulation in the treatment of motor fluctuations in advanced Parkinson's disease | Juan Burguera and Juan Gómez-esteban - Academia.edu
![Direct switch from levodopa/benserazide or levodopa/carbidopa to levodopa/carbidopa/entacapone in Parkinson's disease patients with wearing-off: efficacy, safety and feasibility—an open-label, 6-week study | SpringerLink Direct switch from levodopa/benserazide or levodopa/carbidopa to levodopa/carbidopa/entacapone in Parkinson's disease patients with wearing-off: efficacy, safety and feasibility—an open-label, 6-week study | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00702-009-0344-4/MediaObjects/702_2009_344_Fig1_HTML.gif)